OptimizeRx Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
215.80
1,025.40
595.10
1,539.20
2,104.00
226.30
Depreciation, Depletion & Amortization
193.80
264.30
334.00
235.30
324.60
316.50
Other Funds
418.60
1,175.50
612.80
559.30
968.10
2,523.20
Funds from Operations
828.30
414.50
351.60
744.60
811.40
3,066.10
Changes in Working Capital
304.40
470.80
163.50
278.70
668.50
2,273.50
Net Operating Cash Flow
1,132.60
56.40
515.10
466.00
1,479.80
792.60
Capital Expenditures
298.60
410.00
101.00
349.50
42.20
Net Investing Cash Flow
298.60
410.00
101.00
349.50
42.20
Net Financing Cash Flow
-
2,795.00
4,346.40
357.40
390.00
Net Change in Cash
834.00
2,328.70
4,760.60
1,172.90
1,912.10
Free Cash Flow
1,132.60
63.30
513.10
644.40
1,522.10
Change in Capital Stock
-
2,795.00
4,346.40
357.40
390.00

About OptimizeRx

View Profile
Address
400 Water Street
Rochester Michigan 48307
United States
Employees -
Website http://www.optimizerx.com
Updated 07/08/2019
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records (EHR), which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. Its services include EHR workflow solutions such as financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A.